Kyowa Hakko Kirin | 4151 - Selling And Administration Expenses


Kyowa Hakko Kirin reported JPY38.91B in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Astellas Pharma JPY 215.29B 225M Sep/2026
Chugai Pharma JPY 32.37B 3.32B Sep/2026
Daiichi Sankyo JPY 237.75B 12.21B Sep/2026
Eisai JPY 120.4B 5.58B Sep/2026
Kyowa Hakko Kirin JPY 38.91B 4.83B Sep/2026
M3 JPY 29.29B 1.48B Sep/2026
Otsuka Holdings JPY 281.85B 7.41B Sep/2026
Shionogi JPY 45.31B 161M Sep/2026
Sumitomo Dainippon JPY 39.48B 242M Sep/2026
Takeda JPY 271.71B 14.8B Sep/2026
Terumo JPY 109.58B 120M Sep/2026